Filter
1131
Filtered Results: 1131
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
108
New Publications
284
Language
Document type
No document type
520
Studies & Reports
233
Guidelines
192
Manuals
79
Strategic & Response Plan
59
Fact sheets
20
Training Material
14
Situation Updates
8
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
52
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
30
Nigeria
25
South Africa
18
Ghana
17
Sierra Leone
15
Uganda
15
Zimbabwe
14
Bangladesh
14
Ukraine
14
Philippines
13
Nepal
13
Malawi
13
Zambia
12
Tanzania
12
Rwanda
12
Eastern Europe
12
Latin America and the Carribbean
11
Africa
11
Namibia
10
South–East Asia Region
10
Eswatini/ Swaziland
8
Eastern Europe and Central Asia
8
Liberia
7
Syria
7
Indonesia
7
Myanmar / Burma
7
Botswana
6
West and Central Africa
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Egypt
3
Middle East and North Africa
3
Western Pacific Region
3
Asia
3
Congo, Democratic Republic of
2
Cameroon
2
Jordan
2
Germany
2
Lebanon
2
Sudan
2
Benin
2
North Macedonia
2
Serbia
2
Lesotho
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
United Kingdom
2
Guinea
1
Mali
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Afghanistan
1
China
1
Mozambique
1
Papua New Guinea
1
Libya
1
Madagascar
1
Chile
1
Fiji
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
383
Clinical Guidelines
107
Public Health
69
Key Resources
44
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
9
Toolboxes
AMR
136
Pharmacy
133
COVID-19
81
TB
57
Mental Health
56
HIV
52
Rapid Response
48
Planetary Health
27
Caregiver
26
Global Health Education
25
Conflict
22
NCDs
22
NTDs
21
Health Financing Toolbox
16
Specific Hazards
12
Ebola
10
Polio
8
Disability
7
Refugee
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
Revised Edition
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati...
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo...
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
